MedTrace Logo

Safety and Efficacy of Daptomycin for the Treatment of Complicated Skin and Skin-structure Infections

NCT00463801 · Status: TERMINATED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 52

Last updated 2011-03-24

Study results available
· View outcomes & findings →

Summary

This study will evaluate the safety and efficacy of daptomycin against complicated skin and skin-structure infections in adults

Conditions

  • Staphylococcal Skin Infections

Interventions

DRUG

Daptomycin

Sponsors & Collaborators

Principal Investigators

  • Novartis · Novartis

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2007-01-31
Primary Completion
2007-11-30

Countries

  • Italy

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00463801 on ClinicalTrials.gov